Siemens Stock Gains Momentum on Strong Fundamentals and AI Tailwinds

Siemens raises FY profit guidance, reports record €120B backlog, and accelerates €6B buyback. Strong data center demand and AI partnerships fuel growth.

Siemens AG is presenting investors with a compelling mix of strategic financial management and robust operational performance, underscored by the accelerating artificial intelligence revolution. Recent corporate actions and financial results paint a picture of a company capitalizing on current trends while proactively managing its portfolio.

Revised Guidance and Record Backlog Signal Strength

The industrial conglomerate recently reinforced investor confidence by raising its full-year profit forecast. On February 12, Siemens increased its earnings per share (EPS pre PPA) guidance to a range of €10.70 to €11.10. This upgrade follows a solid first quarter for fiscal 2026, where comparable orders rose approximately 10% to about €21.4 billion, with revenue increasing around 8%. The industrial business segment saw profit grow 15% to €2.9 billion, achieving a margin of 15.6%.

A particularly strong indicator of future revenue is the company's order backlog, which has climbed to a record €120 billion. This gives Siemens a book-to-bill ratio of 1.12. Earnings per share for the quarter reached €2.80, up from an adjusted €2.22 in the prior-year period. Management has also confirmed its outlook for comparable revenue growth of 6% to 8% for 2026, with CFO Ralf Thomas noting that performance is now expected to land in the upper half of that range.

Accelerated Share Buybacks Reshape Capital Structure

Siemens is executing its share repurchase program at a notable pace. Between February 16 and 22, the company bought back an additional 354,983 of its own shares via the Xetra trading platform. This activity is part of a broader plan announced in November 2023, which authorizes the repurchase of up to €6 billion in stock over a maximum of five years.

The speed of the buyback is striking. In roughly two years, Siemens has already deployed nearly €4.4 billion of the authorized amount. In a related move to streamline its capital structure, the company plans to cancel 18 million treasury shares in March. This will reduce the total number of outstanding shares (share capital) to 782 million.

Data Center Demand and AI Partnerships Fuel Growth

A significant source of current momentum is the booming demand for data center infrastructure, largely driven by AI. Orders from this segment totaled €1.8 billion in the quarter, with particularly vigorous growth in the United States. U.S. orders surged 54%, while revenue in the segment jumped 35%. CEO Roland Busch stated during the earnings call that demand has "materially" exceeded expectations.

Concurrently, Siemens is expanding its industrial AI partnerships with leaders like NVIDIA and Microsoft. The collaborations aim to develop AI-accelerated solutions spanning the entire product and production lifecycle. Beginning in 2026, the Siemens Electronics Factory in Erlangen is slated to serve as a blueprint for this integrated approach.

Within its Digital Industries software unit, Annual Recurring Revenue (ARR) grew organically by 10% year-over-year. However, the company itself has pointed out that AI presents medium-term risks to its core industrial software business, highlighting a key area for ongoing observation.

Corporate Restructuring and Market Performance

Further shaping the corporate landscape is a planned portfolio change. Siemens intends to divest its majority stake in Healthineers, transferring approximately 30% of the shares directly to Siemens shareholders via a spin-off. The transaction requires approval from both companies' annual general meetings as well as regulatory clearances. Additional details regarding the timeline and structure are anticipated in early Q2 2026.

In market action, Siemens shares closed the week at €246.20, representing a decline of 1.18% and trading slightly below the 50-day moving average of €250.66. The next key milestone for investors is May 13, 2026, when the company is scheduled to release its next quarterly figures, ahead of the expected Healthineers transaction details in early Q2 2026.